Clinical Trials Browser

OTHER × Hypersensitivity × Rituximab × Clear all

NCT01206777 2017-12-20

Feasibility Study of a 60 Minute Rapid Infusion Rituximab Protocol in Patients With B-cell Malignancies

Phase 2 Completed

52 enrolled 4 charts

Hypersensitivity